Compounds > phenylalanine

phenylalanine and Keratoconjunctivitis Sicca

phenylalanine has been researched along with Keratoconjunctivitis Sicca in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Chhabra, S; Conto, JE; Hamadani, M; Hari, PN; Jerkins, JH; Shah, NN; Zellner, K1
de Paiva, CS; Guimaraes de Souza, R; Pflugfelder, SC; Stern, ME; Yu, Z1
Franko, J; Patel, J1

Other Studies

3 other study(ies) available for phenylalanine and Keratoconjunctivitis Sicca

ArticleYear
Lifitegrast ophthalmic solution for treatment of ocular chronic graft-versus-host disease.
    Leukemia & lymphoma, 2020, Volume: 61, Issue:4

    Topics: Chronic Disease; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Keratoconjunctivitis Sicca; Phenylalanine; Prospective Studies; Retrospective Studies; Sulfones

2020
Suppression of Th1-Mediated Keratoconjunctivitis Sicca by Lifitegrast.
    Journal of ocular pharmacology and therapeutics : the official journal of the Association for Ocular Pharmacology and Therapeutics, 2018, Volume: 34, Issue:7

    Topics: Animals; Chemokine CXCL11; Chemokine CXCL9; Dry Eye Syndromes; Female; Inflammation; Interferon-gamma; Keratoconjunctivitis Sicca; Mice; Mice, Inbred C57BL; Ophthalmic Solutions; Phenylalanine; Sulfones; Th1 Cells

2018
Lifitegrast Ophthalmic Solution 5% (Xiidra) for Dry Eye Disease.
    American family physician, 2018, 07-15, Volume: 98, Issue:2

    Topics: Administration, Ophthalmic; Humans; Keratoconjunctivitis Sicca; Ophthalmic Solutions; Phenylalanine; Randomized Controlled Trials as Topic; Sulfones

2018